Atopic dermatitis (AD) and psoriasis are common skin diseases characterized by cutaneous inflammation and disturbed epidermal differentiation. Genome-wide analyses have shown overlapping susceptibility loci, such as the epidermal differentiation complex on chromosome 1q21. Recently, a deletion on 1q21 (LCE3C_LCE3B-del), comprising LCE3B and LCE3C, two members of the late cornified envelope (LCE) gene cluster, was found to be associated with psoriasis. Although the mechanistic role of LCE proteins in psoriasis has not been identified, these proteins are putatively involved in skin barrier formation and repair. Considering the potential genetic overlap between the two diseases and the recent finding that mutations in the skin barrier protein filaggrin are associated with AD, we investigated a possible association between LCE3C_LCE3B-del and AD. Evaluation of four different cohorts of European ancestry, containing a total of 1075 AD patients and 1658 controls, did not provide evidence for such an association. Subgroup analysis did not reveal an association with concomitant asthma. Our data suggest that the potential roles of skin barrier defects in the pathogenesis of AD and psoriasis are based on distinct genetic causes.
INTRODUCTION
Atopic dermatitis (AD) and psoriasis are clinically distinct, chronic inflammatory skin diseases with a strong genetic basis (Leung and Bieber, 2003; Bowcock and Cookson, 2004; Krueger and Bowcock, 2005) . Several genome-wide analyses have been performed to discover genetic factors contributing to AD and psoriasis (Cookson, 2004) . These analyses have revealed chromosomal regions harboring possible susceptibility loci for both diseases, including chromosomal regions 1q21, 3q21, 17q25, and 20p12. These findings suggested that AD and psoriasis could share some contributing genetic factors, but none of these have been identified to date (Willis-Owen et al., 2007) .
Although both diseases are generally regarded as immunemediated conditions, recent genetic studies have indicated the importance of inherited abnormalities of epidermisexpressed genes as a primary cause (Magert et al., 1999; Chavanas et al., 2000; Cookson, 2004; Palmer et al., 2006; Hollox et al., 2008; De Cid et al., 2009) . These findings are in line with the concept of inflammatory epithelial disease, which was coined previously for a number of conditions that were associated with epithelium-expressed genes and immunological mechanisms (Cookson, 2004) . The shared locus on chromosome 1q21 overlies the epidermal differentiation complex (EDC), a cluster of genes encoding proteins found in the uppermost layers of the epidermis, which are of great importance for keratinocyte differentiation and skin barrier maintenance (Mischke et al., 1996) . Genes located in the EDC include loricrin, involucrin, filaggrin (FLG), the small proline-rich protein genes, the S100 genes, and the late cornified envelope (LCE) genes. Null mutations in the FLG gene have been identified as a remarkably strong and widely replicated risk factor for AD and led to a paradigm shift, placing the barrier function of the skin into the center of the pathogenetic concepts (Irvine and McLean, 2006; Palmer et al., 2006; Smith et al., 2006; Weidinger et al., 2006 Weidinger et al., , 2008 Fallon et al., 2009) . Interestingly, also the cytokine environment associated with AD (Th2 cytokines) appears to contribute to compromised skin barrier function, as IL-4 and IL-13 suppress FLG gene expression (Howell et al., 2007) . In contrast to the genetic findings for AD, no associations of FLG null alleles with psoriasis could be shown (Huffmeier et al., 2007; Zhao et al., 2007) .
Although FLG mutations account for 13% of the population attributable risk in AD (O'Regan et al., 2008) , they only partially explain the linkage signal of AD to the EDC . In addition, in a recent large-scale genome-wide association study, evidence for additional AD risk factors in the EDC, apart from prevalent FLG mutations, was obtained (Esparza-Gordillo et al., 2009) .
Apart from single-nucleotide polymorphisms (SNPs), DNA copy number variation represents a considerable source of human genetic diversity (Redon et al., 2006; Korbel et al., 2007; Kidd et al., 2008 ). De Cid et al. (2009 discovered that the deletion of two genes of the LCE gene family, LCE3B and LCE3C (annotated as LCE3C_LCE3B-del), located in the EDC, was significantly associated with psoriasis in individuals of European ancestry. This finding has recently been replicated by an independent study in German psoriasis patients (Huffmeier et al., 2009 ). In addition, in an independent genome-wide association study of a Chinese cohort, association with SNPs in a strong linkage disequilibrium with the deletion were identified as risk factors for psoriasis (Zhang et al., 2009) . LCE proteins are incorporated in the cornified envelope during epidermal differentiation, as shown by Marshall et al. (2001) . The work by De Cid et al. (2009) suggests that one of the psoriasis-associated genes, LCE3C, is involved in repair of skin barrier function, as its expression is only induced upon epidermal activation.
These observations together with the role of skin barrier maintenance in both diseases prompted us to investigate a possible genetic association between the LCE3C_LCE3B-del allele and AD. Our analysis of four European case-control cohorts, a total of over 2500 samples, however, did not support such an association.
RESULTS

Analysis of association of LCE3C_LCE3B-del with AD
To investigate a possible association of AD with the deletion of the LCE3B and LCE3C genes, we genotyped four European case-control cohorts, consisting of adult cases from The Netherlands and Germany and children with AD from Ireland and Italy (see Table 1 and Supplementary Information for cohort summaries and description). The Dutch, German, and Irish cohort were genotyped by using the direct PCR-based method described by De Cid et al. (2009) . The Italian cohort was genotyped by analyzing SNP rs4112788, which can be used as a proxy for the deletion as it is in strong linkage disequilibrium with the deletion (r 2 ¼ 0.928 and D 0 ¼ 0.988) (De Cid et al., 2009 ). In the different control groups, frequencies of the LCE3C_LCE3B-del allele varied between 59 and 66%. This heterogeneity of the control groups in different ethnic backgrounds was already known from our previous study (De Cid et al., 2009 ). In the Dutch cohort, we found a significantly higher frequency of the LCE3C_LCE3B-del allele in AD patients (66%) compared with healthy controls (59%) (Supplementary Table  1 ). Further analysis were performed by using logistic regression models, in which the wt/wt genotype (homozygous for the undeleted LCE3C_LCE3B allele) was used as reference category. For the Dutch cohort, these analyses showed only for the del/del genotype (homozygous for the LCE3C_LCE3B deletion) a significant association with AD (P ¼ 0.022), corresponding odds ratio (OR) of 1.71 (95% confidence interval (95% CI): 1.08-2.70). For the del/wt genotype (heterozygous for the LCE3C_LCE3B deletion) no association with AD was found (P ¼ 0.420) ( Table 2 ). In none of the other cohorts a significant association with AD and the del/del genotype was found (Table 2 ). For the del/wt genotype a significant association was found in the German cohort (P ¼ 0.018), which was in the opposite direction to the Dutch cohort (OR 0.52, 95% CI: 0.31-0.90). When all cohorts were combined to increase statistical power (Table 2, combined power is 1.0), no significant association was detected for either of the two genotypes (P ¼ 0.665 and 0.945). It has to be noted, however, that for the del/del analysis significant heterogeneity was found between the cohorts. Atopic dermatitis (AD) þ asthma is a subgroup of the AD cohort. (%) Is the percentage of the total AD cohort, which is present in the AD þ asthma cohort. Ratio, control/case ratio.
Analysis of association of LCE3C_LCE3B-del with AD þ asthma or serum IgE
Subgroup analysis of the different AD cohorts revealed that the Dutch cohort, which showed a significant association, contained a higher percentage of patients with concomitant asthma (58 versus 18-32% in the other cohorts). In this cohort, we found a significantly higher frequency of the LCE3C_LCE3B-del allele in the subgroup of AD þ asthma patients (66%) compared with healthy controls (59%) (Supplementary Table 2 ). In contrast, logistic regression models, again using wt/wt as reference, showed no association for the del/wt genotype with AD þ asthma (P ¼ 0.350, OR 1.30, 95% CI: 0.75-2.26, Table 3 ). For the del/del genotype an association of borderline significance was found for AD þ asthma (P ¼ 0.057, OR 1.71, 95% CI: 0.98-2.98) ( Table 3) . Stratification for asthma in the other cohorts, however, did not reveal significant associations between AD þ asthma and LCE3C_LCE3B-del (Table 3) . For the del/wt genotype an association of borderline significance for LCE3C_LCE3B-del and AD þ asthma was found in the German cohort (P ¼ 0.059), which was in the opposite direction to the Dutch cohort (OR 0.50, 95% CI: 0.24-1.03).
Combining all AD þ asthma data from the four cohorts, to increase statistical power (see Table 3 combined power is 1.0), revealed no significant association of asthma þ AD and the LCE3B_LCE3C-del allele (n ¼ 2049, P ¼ 0.416 and 0.103 for the del/wt and del/del genotypes, respectively, Table 3 ). As a region on 1q21 in close proximity to the LCE cluster was previously reported to be associated with total serum IgE levels (Sharma et al., 2007) , we further examined the association of the LCE3C_LCE3B-del allele with total serum IgE levels in our Dutch cohort. As expected, the cases (mean total IgE 115 kU l
À1
) had significantly higher total IgE serum levels than the controls (mean total IgE 20.7 kU l À1 , Po0.001). However, analysis of variance did not show differences in IgE serum levels for the different genotypes within the patient groups separately and overall (P ¼ 0.351, data not shown).
DISCUSSION
Our analysis of the association of LCE3C_LCE3B-del and AD showed varying results in the different cohorts. A significant positive association was found in the Dutch cohort, whereas a weak association in the opposite direction was found for the del/wt genotype in the German cohort. The apparent association found in the Dutch cohort might be due to population heterogeneity, or could be a false-positive finding resulting from small cohort sizes. Because of the high linkage disequilibrium between SNP rs4112788 and LCE3B_LCE3C-del (r 2 ¼ 0.928 and D 0 ¼ 0.988), although admittedly not absolute, we decided to include both the LCE3C_LCE3B-del and the rs4112788 results (Italian data set) in our overall analysis. On the basis of the combined results, we conclude that there is no evidence for association of LCE3C_LCE3B-del and AD in individuals of European ancestry. These results underline the importance of replication studies. Similarly, we did not detect an association of LCE3C_LCE3B-del and AD þ asthma. It has to be noted, however, that the power to detect an effect for AD þ asthma was smaller than that for AD alone. For the AD þ asthma phenotypes, the power of the individual cohorts is rather small (Table 3) ; however, the power of combined analysis both in AD and AD þ asthma is 1.0. It should be noted that for a part of the Dutch control cohort, the Irish and Italian control cohorts no information about asthma status was available, which may limit the interpretation of our analysis.
Previous studies on FLG and LCE3C_LCE3B-del have indicated that polymorphisms and mutations in genes encoding skin barrier proteins make a sizeable contribution to the genetic basis of both AD (estimated population attributable risk of FLG is 13% (O'Regan et al., 2008) ) and psoriasis (estimated population attributable risk of LCE3C_ LCE3B-del is 21% (De Cid et al., 2009) ). For AD it is very likely that FLG mutations directly affect barrier function of normal skin and contribute to percutaneous antigen priming and the subsequent immunological sequelae leading to overt disease (Fallon et al., 2009 ). In the case of psoriasis, the role of the deleted LCE genes is less clear as they are not normally expressed in intact skin, but only induced upon activation. Preliminary findings from our laboratory indicate that this is also true for LCE3B and LCE3C expression in AD (data not shown). It was recently suggested that other genes of the EDC contribute to AD, and clearly there are many other plausible candidate genes in this region, which may on their own or through interaction with FLG lead to barrier dysfunction and AD . As there was no convincing association between LCE3C_LCE3B-del and AD, we did not further investigate a possible interaction with FLG null alleles. We conclude that, despite the shared locus on chromosome 1, the psoriasis-associated deletion of LCE3 genes does not contribute to AD. Our data indicate that the potential roles of skin barrier defects in the pathogenesis of AD and psoriasis are based on distinct genetic causes.
MATERIALS AND METHODS
Study populations
A total of 1075 patients and 1658 controls of European origin from four cohorts was investigated. Basic characteristics of the study cohorts are shown in Table 1 , and a detailed description of the study population is given in the Supplementary Information. In all studies informed consent was obtained, and all studies have been approved by the local ethical committees: for the Netherlands, The medical ethics committee of the University Medical Center Groningen and ''Commissie Mensgebonden Onderzoek Arnhem-Nijmegen''; for Germany, ''Bayerische Landesärtzekammer'' Munich and the ethics committee of the University of Bonn; for Italy, the medical ethics committee ''Policlinico Tor Vergata''; and for Ireland, The Research Ethics Committees of Our Lady's Children's Hospital Crumlin (cases) and Trinity College Dublin (Trinity Biobank controls). The investigations were conducted according to the Declaration of Helsinki principles.
Genotyping
The Dutch, German, and Irish cohort were genotyped by using the direct PCR-based method described by De Cid et al. 
Statistical analysis
Descriptive statistics for quantitative values are given as means ± standard deviation. The observed genotype frequencies were compared with the expected Hardy-Weinberg distribution by w 2 -test. Logistic regression models were used to assess the genetic effect of the LCE3C_LCE3B-del allele on AD risk: data from co-dominant and genotype-specific models were calculated (for results from codominant models, see Supplementary Tables 1 and 2 ). Genotypespecific models were used in the main text of this article, as these models are biologically relevant. The presented data in the main text are derived from models that are unadjusted for age and sex. Unadjusted OR and 95% CI were calculated using homozygosity for the undeleted allele (wt/wt) as a reference category. Overall-values present in the tables are adjusted by population. The sex-adjusted analysis for the Italian and Irish cohorts are present in Supplementary  Table 3 . To test if the cohorts show heterogeneity, the CochranMantel-Haenszel statistics were performed, for del/del compared with wt/wt genotypes significant differences were found (P ¼ 0.003). Values for total serum IgE levels were only available from the Dutch cohort. These values were first log-transformed and comparisons were carried out using one-way analysis of variance. The statistical analysis was performed using SPSS software 16.0 (SPSS, Chicago, IL). Power calculations were performed using Stata Software 10.0 (StataCorp LP, College Station, TX), assumptions in the power analysis (OR of 1.7) were derived from our previous study (De Cid et al., 2009 ).
